Abstract
Several studies have shown the antioxidant and anti-inflammatory effects of licorice extract. This study aims to evaluate the anti-inflammatory and healing effects of licorice extract in acetic acid-induced ulcerative colitis (UC) in rat as an animal model. In summer 2008, forty-eight male Wistar rats were divided into six equal groups. Group I as normal control group received 0.5 ml/kg normal saline; group II, 0.5 ml/kg saline after induction of UC with 3% acetic acid; group III, 50 mg/kg licorice extract orally; group IV, 100 mg/kg licorice extract orally; group V, 150 mg/kg licorice extract orally; and group VI, 150 mg/kg licorice extract intracolonic. In all animals, the distal 10-cm portion of the colon was removed after 7 days for macroscopic and histological investigation. Inflammation following acetic acid administration was characterized by edema, diffuse inflammatory cell infiltration, and necrosis. Administration of oral 100 and 150 mg/kg and intracolonic 150 mg/kg of licorice extract significantly reduced the colonic inflammatory response and edema. Intracolonic administration of licorice extract showed more anti-inflammatory and healing effects in comparison to other groups. Therefore, licorice extract can be suggested as a therapeutic of choice in UC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Strober W, Ludviksson BR, Fuss IJ (1998) The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128:848–856
Williams JG, Hughes LE, Hallett MB (1990) Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 31:187–193
Grisham MB, Volkmer C, Tso P, Yamada T (1991) Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101:540–547
Grisham MB, Gaginella TS, von Ritter C, Tamai H, Be RM, Granger DN (1990) Effects of neutrophils derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 14:531–542
Oz HS, Chen TS, McClain CJ, Villiers WJ (2005) Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem 16:297–304
Kurutas EB, Cetinkaya A, Bulbuloglu E, Kantarceken B (2005) Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-super oxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators Inflamm 6:390–394
Joshi R, Kumar S, Unnikrishnan M, Mukherjee T (2005) Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic Res 39:1163–1172
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286–290
Mehrabani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, Masoumi SJ, Julaee H, Farahmand M, Manafi A (2008) Cancer occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J 10:314–422
Wang GS, Han ZW (1993) The protective action of glycyrrhiza flavonoids against carbon tetrachloride hepatotoxicity in mice. Yao Xue Xue Bao 28:572–576
Asl MN, Hosseinzadeh H (2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22:709–724
Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T (1998) Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 6:339–347
Di Mambro VM, Fonseca MJ (2005) Assays of physical stability and antioxidant activity of a topical formulation added with different plant extract. J Pharm Biomed Anal 37:287–295
MacPherson BR, Pfeiffer CJ (1978) Experimental production of diffuse colitis in rats. Digestion 17(2):135–150
Millar AD, Rampton DS, Chander CL (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39:407–415
Cameron J, Grant Gall D, Wallace JL (1995) Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268:622–630
Appleyard CB, Wallace JL (1995) Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269:119–125
Fabia R, Willen R, Ar'Rajab A, Andersson R, Ahren B, Bengmark S (1992) Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 24:211–225
Kojima R, Hamamoto S, Moriwaki M, Iwadate K, Ohwaki T (2001) The new experimental ulcerative colitis model in rats induced by subserosal injection of acetic acid. Nippon Yakurigaku Zasshi 118:123–130
Sekizuka E, Grisham MB, Li M, Deitch EA, Granger DN (1988) Inflammation-induced intestinal hyperemia in the rat: role of neutrophils. Gastroenterology 95:1528–1534
Kinget R, Kalala W, Vervoort L, van den Mooter G (1998) Colonic drug targeting. J Drug Target 6:129–149
Shibataa N, Tatsuharu Shimokawaa T, Jianga ZQ, Jeonga Y, Ohnoa T, Kimuraa G, Yoshikawaa Y, Kogab K, Murakamia M, Takadaa K (2000) Characteristics of intestinal absorption and disposition of glycyrrhizin in mice. Biopharm Drug Dispos 21:95–101
Baker ME (1994) Licorice and enzymes other than 11 beta-hydroxysteroid dehydrogenase: an evolutionary perspective. Steroids 59:136–141
van Rossum TGJ, Vulto AG, De Man RA, Brouwer JT, Schalm SW (1998) Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 12:199–205
Schröfelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, Szolar OH (2009) Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signaling. Biochem J 421:473–482
Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T (1998) Nuclear factor-κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115:537–569
Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor-κB in inflammatory bowel disease. Gut 42:477–484
Kruidenier L, Verspaget HW (2002) Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment Pharmacol Ther 16:1997–2015
Buffinton GD, Doe WF (1995) Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 19:911–918
Chen G, Zhu L, Liu Y, Zhou Q, Chen H, Yang J (2009) Isoliquiritigenin, a flavonoid from licorice, plays a dual role in regulating gastrointestinal motility in vitro and in vivo. Phytother Res 23:498–506
Isbrucker RA, Burdock GA (2006) Risk and safety assessment on the consumption licorice root, its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 46:167–192
Van Uum SH (2005) Liquorice and hypertension. Neth J Med 63:119–120
Bernardi M, Paola E, D'Intino F, Trevisani G, Maria A, Raggi E, Gasbarrini G (1994) Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci 55:863–872
Acknowledgments
This study was supported by a grant from the Shiraz University of Medical Sciences. We appreciate the collaboration of Stem Cell and Transgenic Technology Research Center of Shiraz University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takhshid, M.A., Mehrabani, D., Ai, J. et al. The healing effect of licorice extract in acetic acid-induced ulcerative colitis in rat model. Comp Clin Pathol 21, 1139–1144 (2012). https://doi.org/10.1007/s00580-011-1249-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-011-1249-9